Table 3. Relative organ weight to body weight of mice fed PSW and LPSW.
Treatment | Liver | Kidneys | Spleen | Lungs | Testes | Brain |
---|---|---|---|---|---|---|
CON | 3.57±0.054 | 1.33±0.047 | 0.26±0.014 | 0.52±0.028 | 0.58±0.021 | 0.78±0.030 |
SCO | 3.42±0.086 | 1.30±0.019 | 0.24±0.009 | 0.47±0.025 | 0.59±0.005 | 0.79±0.023 |
THA10 | 3.50±0.082 | 1.35±0.022 | 0.25±0.014 | 0.49±0.022 | 0.59±0.034 | 0.76±0.029 |
PSW10 | 3.32±0.064 | 1.26±0.026 | 0.24±0.010 | 0.49±0.006 | 0.59±0.019 | 0.75±0.007 |
PSW40 | 3.37±0.100 | 1.26±0.040 | 0.25±0.009 | 0.53±0.014 | 0.58±0.031 | 0.74±0.016 |
LPSW100 | 3.41±0.082 | 1.36±0.036 | 0.28±0.011 | 0.50±0.010 | 0.61±0.014 | 0.74±0.009 |
LPSW400 | 3.43±0.057 | 1.34±0.024 | 0.26±0.014 | 0.49±0.007 | 0.59±0.016 | 0.76±0.014 |
Relative organ weight (%)=(Organ weight/Body weight)×100.
All values are mean±SE.
Control (CON); scopolamine (SCO, 1 mg/kg body weight (B.W.), intraperitoneally (i.p.); tetrahydroaminoacridine 10 [THA 10, tacrine; 10 mg/kg B.W. per oral (p.o.) with SCO (i.p.)]; pig skin water extracts [PSW 10, 10 mg/kg B.W. (p.o.) with SCO (i.p.)]; PSW 40 [40 mg/kg B.W. (p.o.) with SCO (i.p.)]; low molecular weight pig skin water extracts [LPSW 100, 100 mg/kg B.W. (p.o.) with SCO (i.p.)]; LPSW 400 [400 mg/kg B.W. (p.o.) with SCO (i.p.)].